Product NDC: | 0078-0635 |
Proprietary Name: | Signifor |
Non Proprietary Name: | pasireotide |
Active Ingredient(s): | .9 mg/mL & nbsp; pasireotide |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0635 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200677 |
Marketing Category: | NDA |
Start Marketing Date: | 20121214 |
Package NDC: | 0078-0635-20 |
Package Description: | 60 PACKAGE in 1 BOX (0078-0635-20) > 6 AMPULE in 1 PACKAGE (0078-0635-06) > 1 mL in 1 AMPULE (0078-0635-61) |
NDC Code | 0078-0635-20 |
Proprietary Name | Signifor |
Package Description | 60 PACKAGE in 1 BOX (0078-0635-20) > 6 AMPULE in 1 PACKAGE (0078-0635-06) > 1 mL in 1 AMPULE (0078-0635-61) |
Product NDC | 0078-0635 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pasireotide |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20121214 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | PASIREOTIDE |
Strength Number | .9 |
Strength Unit | mg/mL |
Pharmaceutical Classes |